China

 

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
December 15, 2023

FREE BLOG Emerging market providers make up half the Top 50

Half the top 50 listed health care service groups globally by market cap are now headquartered in emerging markets. What does that tell us about the sector internationally?  We publish the top 50 with detailed analysis in Deals and Insights.
August 11, 2023

HBI 2023 Panel: Opportunities in Nursing Homes

As ageing populations collide with a shrinking workforce, nursing homes face an uncertain future. Covid thrust this oft taken-for-granted sector into the spotlight and in the wake of recent scandals in France, three experts weighed in on opportunities and trends in nursing homes at HBI 2023. 
July 20, 2023

Is Orpea set to sell up in Belgium?

Multiple sources tell HBI that French nursing home operator Orpea is looking to sell up in Belgium, as it looks to sell off a chunk of its 1.2bn real estate portfolio. HBI also hears more speculation on the ongoing country-by-country review.
June 30, 2023

China’s new elderly care guidance will create opportunities

China has announced guidance for all provinces to establish a basic elderly care system by the year 2025, according to state-run news channel Xinhua. As the government works to address the impending demographic crisis born largely out of the country's 'one-child policy', HBI speaks to two experts from global strategy firm L.E.K. Consulting to learn more.
May 25, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 
April 19, 2023

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us